Haleon retains outlook as Sensodyne and Centrum bolster third quarter
(Alliance News) - Haleon PLC on Thursday reported a "good performance" in the third quarter, Read More
| Price | 357.90p on 04-11-2025 at 18:50:06 |
|---|---|
| Change | 0.20p 0.06% |
| Buy | 358.00p |
| Sell | 357.80p |
| Last Trade: | Sell 53,520.00 at 357.90p |
| Day's Volume: | 18,918,940 |
| Last Close: | 357.90p |
| Open: | 356.40p |
| ISIN: | GB00BMX86B70 |
| Day's Range | 354.50p - 359.40p |
| 52wk Range: | 325.10p - 419.40p |
| Market Capitalisation: | £31.87b |
| VWAP: | 357.20836p |
| Shares in Issue: | 8.91b |
Haleon (HLN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 53,520 | 357.90p | Automatic Execution |
16:36:03 - 04-Nov-25 |
| Sell* | 835 | 357.90p | SI Trade |
16:35:12 - 04-Nov-25 |
| Sell* | 5,813 | 357.90p | SI Trade |
16:35:12 - 04-Nov-25 |
| Sell* | 113 | 357.90p | SI Trade |
16:35:12 - 04-Nov-25 |
| Buy* | 3,250 | 357.90p | Automatic Execution |
16:35:12 - 04-Nov-25 |
| Buy* | 7,864,838 | 357.90p | Suspected BUY Trade |
16:35:12 - 04-Nov-25 |
| Sell* | 855 | 357.90p | Automatic Execution |
16:29:59 - 04-Nov-25 |
| Sell* | 322 | 357.90p | Automatic Execution |
16:29:59 - 04-Nov-25 |
| Sell* | 754 | 357.90p | Automatic Execution |
16:29:59 - 04-Nov-25 |
| Unknown* | 39 | 358.10p | OTC Trade |
16:29:58 - 04-Nov-25 |
Haleon (HLN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 11:30 am | RNS | Total Voting Rights and Capital |
| 30th Oct 2025 7:00 am | RNS | Haleon 2025 Q3 Trading Statement |
| 10th Oct 2025 12:45 pm | RNS | Director/PDMR Shareholding |
| 2nd Oct 2025 10:05 am | RNS | Director Declaration |
| 2nd Oct 2025 7:00 am | RNS | Transaction in Own Shares & Buyback Update |
| 1st Oct 2025 10:00 am | RNS | Total Voting Rights and Capital |
| 1st Oct 2025 7:00 am | RNS | Transaction in Own Shares |
| 30th Sep 2025 7:00 am | RNS | Transaction in Own Shares |
| 29th Sep 2025 7:00 am | RNS | Transaction in Own Shares |
| 26th Sep 2025 1:30 pm | RNS | Director/PDMR Shareholding |